Local News

• Applied Biosystems reports fourth quarter financial results  Applied Biosystems reported net revenues of $609.0 million for the fourth quarter of fiscal 2008, an increase of 9% over the prior year quarter of $557.3 million. The net effect of foreign currency on net revenues was a favorable impact of approximately 5% compared to the prior year quarter.
  Applied Biosystems July 24, 2008  
• Invitrogen announces second quarter 2008 financial results  Invitrogen announced results for its second quarter ended June 30, 2008. Revenues for the second quarter were $368 million, an increase of 14.3 percent over the $322 million reported for the second quarter of 2007.
  Invitrogen Corporation July 24, 2008  
• Multithreaded supercomputer seeks software for data-intensive computing  Pacific Northwest National Laboratory and Cray Inc. lead a team that received $4 million to develop software for the newest breed of supercomputers to better tackle large networks of seemingly random data, applicable in internet security, power grid stability and complex biological networks.
  Pacific Northwest National Laboratory July 24, 2008  
• Lilly reports second-quarter results  Eli Lilly reported net income and earnings per share grew to $958.8 million in the 2008 second-quarter compared with second-quarter 2007 net income of $663.6 million. Sales increased 11 percent, to $5.150 billion.
  Eli Lilly and Company July 24, 2008  
• Celera reports fourth quarter and fiscal 2008 results  Celera reported net revenues of $43.4 million for the fourth quarter of fiscal 2008, compared to $10.2 million in the prior year quarter. Celera reported a net loss of $96.8 million compared to a net loss of $8.0 million for the prior year quarter.
  Celera Corporation July 23, 2008  
• Genzyme reports strong second-quarter 2008 Growth  Genzyme reported that revenue increased 25 percent to approximately $1.171 billion from $933.4 million in last year’s second quarter. Net income was $69.6 million compared with $83.8 million in the second quarter a year ago.
  Genzyme Corporation July 23, 2008  
• Merck announces fourth quarter 2008 dividend  The Board of Directors of Merck & Co. declared a quarterly dividend of $0.38 per share on the Company's common stock for the fourth quarter of 2008.
  Merck & Co., Inc. July 22, 2008  
• PPD names Christine Dingivan, M.D., Executive Vice President and Chief Medical Officer  PPD announced it has appointed Christine Dingivan, M.D., as executive vice president and chief medical officer. Prior to joining PPD, Dr. Dingivan spent 12 years with MedImmune. She most recently served as senior vice president of clinical development and operation.
  PPD, Inc. July 22, 2008  
• Medicare act extending longstanding reimbursement policy for brachytherapy seeds enacted  Theragenics announced favorable developments in Medicare reimbursement policies related to brachytherapy. On July 15, 2008, the Medicare Improvements for Patients and Providers Act of 2008 was enacted into law.
  Theragenics Corporation July 21, 2008  
• Trimeris reports second quarter 2008 FUZEON(R) sales results  Trimeris announced net sales of FUZEON for the second quarter of 2008 were $38.3 million, down 38 percent from $62.0 million in the second quarter of 2007. Net sales of FUZEON in the U.S. and Canada for the second quarter of 2008 were $16.1 million, down 51 percent from the second quarter of 2007.
  Trimeris, Inc. July 21, 2008  

   (next 10 articles)